抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Ocaratuzumab
All
TD-HY257126_1.jpg
TD-HY257126_2.jpg
- Catalog： TD-HY257126
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： AME-133v, LY2469298, CAS: 1169956-08-4
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Ocaratuzumab
| Catalog No. | TD-HY257126 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Species | Human |
| Clonality | Monoclonal |
| Target | B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20 |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P11836 |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternate Names | AME-133v, LY2469298, CAS: 1169956-08-4 |
| Background | Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC). |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|
|
Detects Human CD20/MS4A1 in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Ocaratuzumab. |